Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A physician-pharmacist model for the surveillance of blood pressure in the community: a feasibility study

Abstract

Hypertension is poorly managed. Hospital-based pharmacists working with physicians have been shown to improve the rate of achievement of ‘target’ blood pressure in selected patients. It is unknown if such schemes can operate in the community and to what extent they would attract volunteers with poorly managed blood pressure. We assessed the feasibility of pharmacists to provide community-based, open-access, blood pressure monitoring. In addition, we describe the blood pressure profile of the group in comparison to that of the 1994 Health Survey of England (HSE). Pharmacists from six pharmacies were trained to deliver the service. Adults living within the postal districts of the pharmacies were invited, through an advertising campaign, to volunteer to have their blood pressure measured. Blood pressure data and information on treatment for hypertension and/or diabetes were collected on 263 registrants. Patients were advised to have their blood pressure managed by the general practitioner immediately (category 1), re-measured within 2–3 months (category 2) or in 12 months time (category 3). The mean (s.d.) blood pressure of patients in categories 1 (n = 16), 2 (n = 117) and 3 (n = 130) was 186(16)/97(29), 151(13)/94(9) and 139(22)/86(13) mm Hg respectively; P < 0.001. Ninety-one patients (35%) were in receipt of antihypertensive therapy. Forty-five percent of the treated group had controlled blood pressure (<160/95 mm Hg) compared with 30% in the HSE dataset. A large proportion of known hypertensive patients with poor blood pressure control who had visited their general practitioner within the previous 6 months were detected by the pharmacist-led service. Pharmacists operating an open-access blood pressure monitoring service may be of value in improving the management of hypertension.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Collins R, MacMahon S Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease Br Med Bull 1994 50 272–298

    Article  CAS  Google Scholar 

  2. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 1991 265 3255–3264

    Article  Google Scholar 

  3. Colhoun HM, Dong W, Poulter NR Blood pressure screening, management and control in England; results from the Health Survey for England 1994 J Hypertens 1998 16 747–752

    Article  CAS  Google Scholar 

  4. Du X et alCase-control study of stroke and the quality of hypertension control in north west England BMJ 1997 314 272–276

    Article  CAS  Google Scholar 

  5. Berlowitz DR et alInadequate management of blood pressure in a hypertensive population N Engl J Med 1998 339 1957–1963

    Article  CAS  Google Scholar 

  6. Erickson SR, Slaughter R, Halapy H Pharmacists’ ability to influence outcomes of hypertension therapy Pharmacotherapy 1997 17 140–147

    CAS  PubMed  Google Scholar 

  7. Bogden PE et alComparing standard care with a physician and pharmacist team approach for uncontrolled hypertension J Gen Int Med 1998 13 740–745

    Article  CAS  Google Scholar 

  8. O’Brien E, Mee F, Atkins N, Thomas M Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175 Blood Press Monit 1996 1 55–61

    PubMed  Google Scholar 

  9. Ramsay LE et alBritish Hypertension Society guidelines for hypertension management 1999: a summary BMJ 1999 319 630–635

    Article  CAS  Google Scholar 

  10. 1991 Census Report of Greater London. Part I. Office of Population Censuses and Surveys Stationery Office, London, United Kingdom

  11. National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension Arch Intern Med 1993 153 186–208

  12. Stamler J, Wentworth D, Neaton JD, for the MRFIT Research Group Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT) JAMA 1986 256 2823–2828

    Article  CAS  Google Scholar 

  13. O’Connor AM et alDecision aids forpatients facing health treatment or screening decisions: systematic review BMJ 1999 319 731–734

    Article  Google Scholar 

  14. McGhee SM et alCoordinating and standardising long-term care: evaluation of the west of Scotland shared care scheme for hypertension Br J Gen Prac 1994 44 441–445

    CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Liz Denver and Alison Holmes for assisting with the blood pressure training programme, and are most grateful to all the pharmacists who voluntarily participated in this pilot study. SW was supported by a research grant from Zeneca Pharmaceuticals. Solvay Healthcare provided support for the purchase of the Omron blood pressure monitors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to KA Earle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Earle, K., Taylor, P., Wyatt, S. et al. A physician-pharmacist model for the surveillance of blood pressure in the community: a feasibility study. J Hum Hypertens 15, 529–533 (2001). https://doi.org/10.1038/sj.jhh.1001220

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001220

Keywords

This article is cited by

Search

Quick links